[go: up one dir, main page]

WO2007057919A3 - An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine - Google Patents

An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine Download PDF

Info

Publication number
WO2007057919A3
WO2007057919A3 PCT/IN2006/000355 IN2006000355W WO2007057919A3 WO 2007057919 A3 WO2007057919 A3 WO 2007057919A3 IN 2006000355 W IN2006000355 W IN 2006000355W WO 2007057919 A3 WO2007057919 A3 WO 2007057919A3
Authority
WO
WIPO (PCT)
Prior art keywords
improved process
pentanoyl
tetrazol
ylmethyl
prop
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2006/000355
Other languages
French (fr)
Other versions
WO2007057919A2 (en
Inventor
Pandurang Balwant Deshpande
Anand Kumar Pandey
Parven Kumar Luthra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alembic Ltd
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of WO2007057919A2 publication Critical patent/WO2007057919A2/en
Publication of WO2007057919A3 publication Critical patent/WO2007057919A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An improved process for prepariang Valsartan of formula (I), by carrying out hydrolysis of Valsartan ester derivative of formula (II) in presence of phase transfer catalyst.
PCT/IN2006/000355 2005-10-25 2006-09-11 An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine Ceased WO2007057919A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1335/MUM/2005 2005-10-25
IN1335MU2005 2005-10-25

Publications (2)

Publication Number Publication Date
WO2007057919A2 WO2007057919A2 (en) 2007-05-24
WO2007057919A3 true WO2007057919A3 (en) 2007-09-20

Family

ID=38049079

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000355 Ceased WO2007057919A2 (en) 2005-10-25 2006-09-11 An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine

Country Status (1)

Country Link
WO (1) WO2007057919A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258312B2 (en) 2007-06-27 2012-09-04 Mylan Laboratories Ltd Process for preparing pure valsartan
EP2260018A2 (en) 2008-04-07 2010-12-15 Hetero Research Foundation Process for preparation of valsartan intermediate
SI3715345T1 (en) * 2012-07-25 2024-07-31 Bausch + Lomb Ireland Limited PREPARATION OF THE LFA-1 INHIBITOR
CN104370961B (en) * 2014-10-27 2016-08-24 三门峡中达化工有限公司 The method of iso-octyl phosphine monooctyl acid monooctyl ester is prepared in a kind of phase transfer catalysis (PTC) hydrolysis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399578A (en) * 1990-02-19 1995-03-21 Ciba-Geigy Corp Acyl compounds
WO2004026847A1 (en) * 2002-09-23 2004-04-01 Novartis Ag Process for the manufacture of valsartan
WO2004111018A1 (en) * 2003-06-16 2004-12-23 Hetero Drugs Limited A novel process for preparation of valsartan
WO2005049586A1 (en) * 2003-11-24 2005-06-02 Belupo-Lijekovi Kozmetika D.D. Process for production of (s) -n-pentanoyl-n-[[2’-(1h-tetrazole-5yl) [1,1’-biphenyl]-4-yl]methyl]-l-valine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399578A (en) * 1990-02-19 1995-03-21 Ciba-Geigy Corp Acyl compounds
WO2004026847A1 (en) * 2002-09-23 2004-04-01 Novartis Ag Process for the manufacture of valsartan
WO2004111018A1 (en) * 2003-06-16 2004-12-23 Hetero Drugs Limited A novel process for preparation of valsartan
WO2005049586A1 (en) * 2003-11-24 2005-06-02 Belupo-Lijekovi Kozmetika D.D. Process for production of (s) -n-pentanoyl-n-[[2’-(1h-tetrazole-5yl) [1,1’-biphenyl]-4-yl]methyl]-l-valine

Also Published As

Publication number Publication date
WO2007057919A2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
WO2008000951A3 (en) Urea derivatives of tropane, their preparation and their therapeutic application
WO2003033524A3 (en) Peptidyl ketones as inhibitors of dpiv
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
WO2008001101A3 (en) Pharmaceutical combinations
WO2009016460A8 (en) Pyrazole compounds and their use as raf inhibitors
WO2008003958A3 (en) Fused pyrimido compounds
WO2010063700A3 (en) Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides
WO2007044085A3 (en) Heteroaryl compounds and their uses as therapeutic agents
WO2008084223A3 (en) Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
WO2007150026A3 (en) Purinone derivatives as hm74a agonists
IL190231A0 (en) Phenyl-and pyridinyl-1,2,4-oxadiazolone derivatives processes for their preparation and their use as pharmaceuticals
WO2008058118A3 (en) Preparation of montelukast and its salts
WO2007121917A3 (en) Purine derivatives as adenosine receptor activator
WO2008151828A3 (en) Novel microbiocides
WO2009153461A3 (en) Method for the synthesis of 7, 8-dimethoxy-l, 3-dihydro-2h-3-benzazepin-2-one, and the application thereof to the synthesis of ivabradine and the addition salts thereof with a pharmaceutically acceptable acid
WO2009127718A3 (en) Novel microbiocides
WO2006029193A3 (en) Process for preparing substituted tetrazoles from aminotetrazole
WO2008007153A3 (en) Antiviral compounds
MX2009005423A (en) Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2, 6-piperazinedione).
WO2007032019A3 (en) Process for preparing valsartan
WO2008019030A3 (en) Modified azole compounds as antiinfective agents
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
WO2007057919A3 (en) An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
WO2006107062A3 (en) Benzimidazole derivative and use as angiotensin ii antagonist
WO2008099416A3 (en) Novel benzothiazole and benzoxazole linked pyrrolo[2,1-c] [1, 4] benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase

Ref document number: 06842744

Country of ref document: EP

Kind code of ref document: A2